Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Michael J. Hass"'
Autor:
Justin D. Smith, Wynne E. Norton, Sandra A. Mitchell, Christine Cronin, Michael J. Hassett, Jennifer L. Ridgeway, Sofia F. Garcia, Raymond U. Osarogiagbon, Don S. Dizon, Jessica D. Austin, Whitney Battestilli, Joshua E. Richardson, Nathan K. Tesch, David Cella, Andrea L. Cheville, Lisa D. DiMartino, the IMPACT Consortium
Publikováno v:
Implementation Science Communications, Vol 4, Iss 1, Pp 1-13 (2023)
Abstract Background Systematic approaches are needed to accurately characterize the dynamic use of implementation strategies and how they change over time. We describe the development and preliminary evaluation of the Longitudinal Implementation Stra
Externí odkaz:
https://doaj.org/article/49a6f053ada24ba48fb525cc9b4b4154
Autor:
Adith Abraham, Carlos H. Barcenas, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Ellis G. Levine, Nancy U. Lin, Beverly Moy, Joyce C. Niland, Antonio C. Wolff, Michael J. Hassett, Sarah Asad, Daniel G. Stover
Publikováno v:
Breast, Vol 67, Iss , Pp 89-93 (2023)
Background: Most metastatic recurrences of triple negative breast cancer (TNBC) occur within five years of diagnosis, yet late relapses of TNBC (lrTNBC) do occur. Our objective was to develop a risk prediction model of lrTNBC using readily available
Externí odkaz:
https://doaj.org/article/5c83b462165b47969c3d65f9cfdccfde
Autor:
Harry Klein, Tali Mazor, Ethan Siegel, Pavel Trukhanov, Andrea Ovalle, Catherine Del Vecchio Fitz, Zachary Zwiesler, Priti Kumari, Bernd Van Der Veen, Eric Marriott, Jason Hansel, Joyce Yu, Adem Albayrak, Susan Barry, Rachel B. Keller, Laura E. MacConaill, Neal Lindeman, Bruce E. Johnson, Barrett J. Rollins, Khanh T. Do, Brian Beardslee, Geoffrey Shapiro, Suzanne Hector-Barry, John Methot, Lynette Sholl, James Lindsay, Michael J. Hassett, Ethan Cerami
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-9 (2022)
Abstract Widespread, comprehensive sequencing of patient tumors has facilitated the usage of precision medicine (PM) drugs to target specific genomic alterations. Therapeutic clinical trials are necessary to test new PM drugs to advance precision med
Externí odkaz:
https://doaj.org/article/0c617a60fa3f432c8f9c2b34b3ebd0b8
Publikováno v:
Organic Letters. 13:3522-3525
The intramolecular cycloisomerization of 1,6-enynes in 95-99% ee is reported using an immobilized Rh catalyst-organic framework synthesized from alternating ring-opening metathesis polymerization (altROMP) assembly. The framework was reused up to sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c039da099d476b9e7fd0f4ac1a10fa
https://doi.org/10.1021/ol201333s
https://doi.org/10.1021/ol201333s
Autor:
Dario Trapani, Kiu Tay-Teo, Megan E. Tesch, Felipe Roitberg, Manju Sengar, Sara C. Altuna, Michael J. Hassett, Armando A. Genazzani, Aaron S. Kesselheim, Giuseppe Curigliano
Publikováno v:
Current Oncology, Vol 29, Iss 8, Pp 5774-5791 (2022)
Background: Advances in cancer medicines have resulted in tangible health impacts, but the magnitude of benefits of approved cancer medicines could vary greatly. Health Technology Assessment (HTA) is a multidisciplinary process used to inform resourc
Externí odkaz:
https://doaj.org/article/f8f024b9d7d74d429ae34560c195d643
Autor:
Michael J. Hassett, Sandra Wong, Raymond U. Osarogiagbon, Jessica Bian, Don S. Dizon, Hannah Hazard Jenkins, Hajime Uno, Christine Cronin, Deborah Schrag, SIMPRO Co-Investigators
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Background Many cancer patients experience high symptom burden. Healthcare in the USA is reactive, not proactive, and doctor-patient communication is often suboptimal. As a result, symptomatic patients may suffer between clinic visits. In re
Externí odkaz:
https://doaj.org/article/5ce5a410bf42457ab9cd88b98ace1cf4
Autor:
Gabriella Lui, Michael J. Hassett, MD, MPH, Angela C. Tramontano, MPH, Hajime Uno, PhD, Rinaa S. Punglia, MD, MPH
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101017- (2022)
Purpose: We examined radiation therapy (RT) use among patients with early-stage breast cancer and analyzed the contribution of patient, cancer, and regional factors to the likelihood of RT receipt across Health Service Areas. Methods and Materials: W
Externí odkaz:
https://doaj.org/article/a3d72ca7312948a8a62eae513046bf7f
Autor:
David D. Yang, Daniela L. Buscariollo, Angel M. Cronin, Shicheng Weng, Melissa E. Hughes, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Stephen B. Edge, Beverly Moy, Joyce C. Niland, Antonio C. Wolff, Michael J. Hassett, Rinaa S. Punglia
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-7 (2020)
Abstract Background Although the 21-gene recurrence score (RS) assay is widely used to predict distant recurrence risk and benefit from adjuvant chemotherapy among women with hormone receptor-positive (HR+) breast cancer, the relationship between the
Externí odkaz:
https://doaj.org/article/d4bb13507ca44041af2782a5fdc08c31
Publikováno v:
Cancer Medicine, Vol 9, Iss 6, Pp 2019-2029 (2020)
Abstract Background Historically, older patients with advanced lung cancer have often received no systemic treatment. Immunotherapy has improved outcomes in clinical trials, but its dissemination and implementation at the population level is not well
Externí odkaz:
https://doaj.org/article/7a08317698f5481a9a8a59355bb2cce1
Autor:
Kimberly A. Van Orden, Julie Lutz, Kenneth R. Conner, Caroline Silva, Michael J. Hasselberg, Kathleen Fear, Allison W. Leadley, Marsha N. Wittink, Judith F. Baumhauer
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2022)
Background: Patient-reported outcomes (PROs) can promote person-centered biopsychosocial health care by measuring outcomes that matter to patients, including functioning and well-being. Data support feasibility and acceptability of PRO administration
Externí odkaz:
https://doaj.org/article/24eec6de4857491fbebbc4e300a7201d